Amendment (S.Amdt.1034) to S.1082: A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize and amend the prescription drug user fee provisions, and for other purposes.

Back to Main Bill Page
Back to Roll Call Details

May 09, 2007 Roll call number 156 (Amendment number S.Amdt.1034) in the Senate
Question On the Amendment (Durbin Amdt. No. 1034 ) Amendment purpose To reduce financial conflict of interest in FDA Advisory Panels.
Ayes: 47 (Democrat: 42; Republican: 3; Other: 2)
Nays: 47 (Democrat: 7; Republican: 40)
Abstained: 6 (Democrat: 1; Republican: 5)
Required percentage of 'Aye' votes: 1/2 (50%)
Percentage of 'aye' votes: 47%
Result: Amendment Rejected

Republicans Voting 'Nay'

** Because of incomplete data from newly elected Representatives, party breakdown visualizations may be inaccurate by one or two votes.

OpenCongress is a free and open-source joint project of two non-profit organizations, the Participatory Politics Foundation and the Sunlight Foundation.